A5049120769- Heart Failure Treatment and Management
- Pharmaceutical Practices and Patient Outcomes
- Innovations in Medical Education
- Cholinesterase and Neurodegenerative Diseases
- Medical Education and Admissions
- Cardiovascular Function and Risk Factors
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Healthcare professionals’ stress and burnout
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- Pharmaceutical Economics and Policy
- Transplantation: Methods and Outcomes
- Potassium and Related Disorders
- Renal Transplantation Outcomes and Treatments
- Diversity and Career in Medicine
- Patient Safety and Medication Errors
- Cardiac pacing and defibrillation studies
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Antiplatelet Therapy and Cardiovascular Diseases
- Electrolyte and hormonal disorders
- Inflammatory mediators and NSAID effects
- Cardiac Arrhythmias and Treatments
- Workplace Health and Well-being
University of North Carolina at Charlotte
2023-2024
University of Maryland, Baltimore
2013-2022
American College of Clinical Pharmacy
2016-2021
University of North Carolina at Pembroke
2016-2021
Indianapolis Zoo
2016-2021
University of Maryland Medical Center
2017-2018
University of Kentucky HealthCare
2018
East Carolina University
2015
University of Maryland, College Park
2014
University of North Carolina Hospitals
2009-2013
The authors declare no conflicts of interest.
Abstract The Great Resignation marked a dramatic return to the steady, rising rate of job turnover that began over decade ago, and recent reports suggest profession pharmacy is no exception. Rising concerns about pharmacist follow wave articles prevalence burnout in nearly every corner profession. However, this should come as surprise, are often progressively worsening symptoms same disease: toxic work environment. This review suggests many current efforts improve will have limited impact...
Aim: An algorithm that uses clinical factors and CYP2C19 genotype to guide P2Y12 inhibitor selection in high-risk patients undergoing percutaneous coronary intervention was implemented at our institution. We sought evaluate use of this identify which influenced selection. Patients & methods: This retrospective cohort study included 264 receiving from July–December 2012. Results: obtained 229 patients; these, 30% were intermediate or poor metabolizers. metabolizer phenotype among the...
Objectives . To characterize anticoagulation practices with the Impella percutaneous ventricular assist device (pVAD). Background Managing in patients being supported by pVAD is made challenging several unique features of device. These include release a dextrose-based purge solution containing unfractionated heparin (UFH), need to concurrently administer systemic intravenous UFH, and lack an alternative strategy contraindications UFH. Methods pVAD, we conducted survey centers United States...
The use of an argatroban-based percutaneous ventricular assist device (pVAD) purge solution in a patient with suspected heparin-induced thrombocytopenia (HIT) is described. A 70-year-old woman cardiogenic shock was admitted to coronary care unit after being discovered unresponsive at home. transthoracic echocardiogram revealed low ejection fraction and findings consistent takotsubo cardiomyopathy. Administration multiple inotropes vasopressors initially required for hemodynamic support....
To assess the efficacy and safety of intravenous (IV) chlorothiazide versus oral metolazone when added to loop diuretics in patients with acute decompensated heart failure (ADHF) diuretic resistance.Retrospective cohort study.Large urban academic medical center.Adults admitted ADHF between 2005 2015 who had resistance, defined as administration IV furosemide at a dose 160 mg/day or higher (or an equivalent bumetanide), during hospitalization, then received least one (88 patients) (89 augment...
Background: Discharge anticoagulation counseling is important for ensuring patient comprehension and optimizing clinical outcomes. As pharmacy resources become increasingly limited, the impact of informational videos on process becomes more relevant. Objective: To evaluate differences in pharmacist time spent (measured by Oral Anticoagulation Knowledge [OAK] test) between traditional face-to-face (oral) counseling. Methods: This prospective, open, parallel-group study at an academic medical...
The impact of patient-specific factors on the choice β-blocker versus calcium channel blocker therapy for rate control in emergency department (ED) patients treated atrial fibrillation (AF) was investigated.A retrospective cohort study conducted to evaluate influence demographics, prior medication use, hemodynamic and clinical characteristics, other variables selection first-line AF among admitted ED an academic medical center over a 22-month period (October 2012-July 2014) who received i.v....
Study Objective To assess the short-term efficacy and safety of an accelerated intravenous iron regimen in hospitalized patients with heart failure deficiency. Design Prospective, single-arm, open-label study. Setting Large tertiary care medical center. Patients Thirteen New York Heart Association class III–IV failure, anemia (hemoglobin level ≤ 12.0 g/dl), deficiency (ferritin < 100 ng/ml, or ferritin 100–300 ng/ml transferrin saturation 20%) between April 2011 December 2013. Intervention...
The results of an investigation serum magnesium concentrations (SMCs) after i.v. versus oral delivery in cardiovascular critical care are presented.A retrospective case review was conducted to compare the net gain (n = 188) or 164) therapy for prevention ventricular fibrillation and arrhythmias patients hospitalized serious disorders, as determined by assessing SMCs. primary study outcome change from baseline SMC values 6-24 hours completion courses; secondary outcomes included impact renal...